TOXOPLASMOSIS IN VACCINATED COVID-19 PATIENTS | ||||
| Journal of the Egyptian Society of Parasitology | ||||
| Article 21, Volume 53, Issue 2, August 2023, Page 381-386 PDF (1.5 MB) | ||||
| DOI: 10.21608/jesp.2023.312186 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
MARWA AHMED GOUDA 1; HIND SAAD ABOSHABAAN2; AHMED SALAH ABDELGAWAD2; ALIAA SABRY ABDEL WAHED* 3; ASMAA FAHMY IBRAHIM  1
| ||||
| 1Department of Clinical and Molecular Parasitology | ||||
| 2Department of Clinical Pathology | ||||
| 3Department of Hepatology and Gastroenterology, National Liver Institute, Menoufia University, Menoufia Governorate, Egypt | ||||
| Abstract | ||||
| Toxoplasma gondii is associated with viral infections like cytomegalovirus (CMV), and human immunodeficiency virus (HIV), and an important a factor in SARS-COV-2 global pandemic. This study investigated the potential attribution of T. gondii as a risk factor in COVID-19 infection after vaccination and to detect associated hematological and biochemical parameters. Out of 375 COVID-19 patients enrolled in the study, latent toxoplasmosis was detected in 108/375 (28.8%) patients. Regarding hematological parameters, a significant difference was reported in white blood cells, lymphocyte, and neutrophil counts. Biochemical parameters, LDH (426.5±446.4), ferritin (453.71±283.36), and D-dimer (603.43±519.13) were significant among cases. The current work highlights the role of toxoplasmosis in COVID infections following vaccination through the changes in the hematological and biochemical parameters | ||||
| Keywords | ||||
| Toxoplasma gondii; vaccinated COVID-19; Laboratory diagnosis; Biomarkers | ||||
|
Statistics Article View: 155 PDF Download: 108 |
||||
